CTT Pharmaceutical Holdings, Inc. (CTTH)
OTCMKTS · Delayed Price · Currency is USD
0.0400
-0.0010 (-2.44%)
Aug 21, 2025, 4:00 PM EDT
CTT Pharmaceutical Holdings Company Description
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment.
It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion.
Its principal asset is a patented orally administered wafer, an orally administrable wafer comprising at least one physiologically acceptable film forming agent.
The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015.
The company is based in Ottawa, Canada.
CTT Pharmaceutical Holdings, Inc.
| Country | United States |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Ryan Khouri |
Contact Details
Address: 429 Kent Street unit 112 Ottawa, Delaware K2P 2B4 Canada | |
| Phone | 613-241-9959 |
| Website | cttpharmaceuticals.com |
Stock Details
| Ticker Symbol | CTTH |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US12651E1064 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ryan Khouri | Chief Executive Officer and Director |
| Marc Lakmaaker | Special Advisor and Senior Vice President of Commercial Development |